Murine interferon-α
    3.
    发明授权
    Murine interferon-α 有权
    鼠干扰素α

    公开(公告)号:US06902729B2

    公开(公告)日:2005-06-07

    申请号:US10358619

    申请日:2003-02-04

    摘要: Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. The present invention provides a new form of murine interferon-α, which has applications in diagnosis and therapy.

    摘要翻译: 干扰素代表了一类重要的生物制药产品,在治疗各种医疗条件方面具有良好的记录,包括治疗某些自身免疫性疾病,治疗特定癌症,以及增强针对感染因子的免疫应答。 本发明提供了一种新型的鼠干扰素-α,其在诊断和治疗中具有应用。

    Hybrid genes for expression of stimulatory factors in activated T cells
    4.
    发明授权
    Hybrid genes for expression of stimulatory factors in activated T cells 失效
    用于在活化的T细胞中表达刺激因子的杂交基因

    公开(公告)号:US06593124B1

    公开(公告)日:2003-07-15

    申请号:US09213993

    申请日:1998-12-16

    IPC分类号: C12N121

    摘要: Recombinant vectors are provided that render the proliferative response of activated lymphocytes, particularly cytotoxic T lymphocytes, of lessened dependency on T helper cells. The vectors are comprised of a region encoding a stimulatory factor polypeptide operably linked to a heterologous transcriptional control region. Expression of the stimulatory factor polypeptide from the recombinant polynucleotide in an activated lymphocyte renders the proliferative response of less dependent on lymphocyte T helper cells. When the lymphocyte is activated by binding of its cognate antigen the transcriptional control region causes transcription of the stimulatory factor encoding region. The cells containing the vector, particularly CTLs, are of use in immunotherapy.

    摘要翻译: 提供重组载体,其使活化的淋巴细胞,特别是细胞毒性T淋巴细胞的增殖反应减少对T辅助细胞的依赖性。 载体由编码可操作地连接到异源转录控制区的刺激因子多肽的区域组成。 来自重组多核苷酸的刺激因子多肽在活化淋巴细胞中的表达使得对淋巴细胞T辅助细胞较少依赖的增殖反应。 当淋巴细胞通过其同源抗原的结合而被激活时,转录控制区引起刺激因子编码区的转录。 含有载体,特别是CTL的细胞可用于免疫治疗。

    Murine interferon-&agr;
    5.
    发明授权
    Murine interferon-&agr; 失效
    鼠干扰素α

    公开(公告)号:US06312924B1

    公开(公告)日:2001-11-06

    申请号:US09528760

    申请日:2000-03-17

    IPC分类号: C12P2104

    摘要: Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. The present invention provides a new form of murine interferon-&agr;, which has applications in diagnosis and therapy.

    摘要翻译: 干扰素代表了一类重要的生物制药产品,在治疗各种医疗条件方面具有良好的记录,包括治疗某些自身免疫性疾病,治疗特定癌症,以及增强针对感染因子的免疫应答。 本发明提供了一种新型的鼠干扰素-α,其在诊断和治疗中具有应用。

    Testis-specific cystatin-like protein cystatin T
    7.
    发明授权
    Testis-specific cystatin-like protein cystatin T 失效
    睾丸特异性胱抑素样蛋白半胱氨酸蛋白酶抑制剂T

    公开(公告)号:US06235708B1

    公开(公告)日:2001-05-22

    申请号:US09431480

    申请日:1999-11-01

    IPC分类号: A61K3101

    摘要: The present invention relates to cystatin T (also known as zcys3) polypeptides and polynucleotides encoding the same. Cystatin T polypeptide is testis specific and homologous to cystatin-related epididymal specific gene (CRES) and type 2 cystatins. The polypeptides would be useful for modulating spermatogenesis and may be used to study or modulate that function in in vitro or in vivo systems. The present invention also includes antibodies to the cystatin T polypeptides.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶抑制剂T(也称为zcys3)多肽及其编码的多核苷酸。 半胱氨酸蛋白酶抑制剂T多肽是与半胱氨酸蛋白酶抑制剂相关的附睾特异性基因(CRES)和2型胱氨酸蛋白酶特异性并同源的睾丸。 多肽可用于调节精子发生,并且可用于在体外或体内系统中研究或调节该功能。 本发明还包括对半胱氨酸蛋白酶抑制剂T多肽的抗体。